Adelene Q. Perkins, President & Chief Business Officer at INFINITY PHARMACEUTICALS, INC. (INFI), bought 9,200 shares at $7.96 ($73K) on 2008-12-17, disclosed to the SEC on 2008-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.41 | 600 | $4K | 6.1% |
| 2 | $7.42 | 100 | $742 | 1.0% |
| 3 | $7.88 | 420 | $3K | 4.6% |
| 4 | $7.90 | 198 | $2K | 2.2% |
| 5 | $7.90 | 2,000 | $16K | 21.7% |
| 6 | $7.91 | 239 |
| $2K |
| 2.6% |
| 7 | $7.93 | 100 | $793 | 1.1% |
| 8 | $7.94 | 1,000 | $8K | 10.9% |
| 9 | $7.95 | 1,043 | $8K | 11.4% |
| 10 | $7.95 | 100 | $795 | 1.1% |
| 11 | $7.96 | 200 | $2K | 2.2% |
| 12 | $7.96 | 1,000 | $8K | 10.9% |
| 13 | $7.99 | 100 | $799 | 1.1% |
| 14 | $8.00 | 2,100 | $17K | 23.1% |
| Total | $7.90 avg | 9,200 | $73K | 100% |
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |